Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Therapeutic and rehabilitation devices / Ventilators and respiratory support devices for acute and alternate care

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Ventilators and respiratory support devices for acute and alternate care

Hospitals, emergency departments, long-term care and home-care providers buying ventilators (invasive and non-invasive), CPAP/BiPAP, oxygen concentrators and associated circuits, filters and interfaces for acute respiratory support and chronic airway management.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
80 /100
for B2B sellers
Evidence
not sized
3 sources · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Hospitals, respiratory therapy departments, long-term care and home-care providers
Buying centre
Respiratory therapy and critical-care department leadership, with biomedical engineering, infection prevention and procurement; home-care providers add clinical and reimbursement staff
Buying triggers
  • Post-acute respiratory demand and chronic COPD/obesity-hypoventilation caseload growth
  • Shift of respiratory support into the home to free ICU beds and cut cost per episode
  • Ventilator fleet refresh and end-of-life replacement cycles
  • Pandemic-driven surge capacity and stockpiling requirements
Pains
  • Reimbursement and staffing constraints on home ventilator use
  • Consumable cost per patient-day (circuits, filters, interfaces)
  • Device fleet utilisation and matching of device type to patient acuity
  • Regulatory and reimbursement uncertainty for home respiratory therapy
Scores (1–5)
Pain intensity4
Purchasing power4
Reachability4
Growth4

How this was sized

Not sized yet

Bottom-up: global medical device market ~USD 580-640bn in 2026 [4]; respiratory and ventilatory devices are commonly estimated at roughly 10-14% of the device market, implying ~USD 60-85bn globally, of which hospital acute and alternate care ~70% (USD 42-60bn) and home respiratory ~20-25% (USD 12-20bn). Low confidence: segment share is an assumption; no source in the set sizes ventilators or respiratory devices directly. Sources [4][6][9] used only for the total device market anchor.

Alongside it in Therapeutic and rehabilitation devices

// Sell into Ventilators and respiratory support devices for acute and alternate care

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.